首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension.
【24h】

Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension.

机译:乐卡地平的钙拮抗剂治疗可预防原发性高血压的超极化。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Essential hypertension is associated with impaired endothelium-dependent vasodilation caused by oxidative stress-induced nitric oxide (NO) breakdown and compensatory production of a hyperpolarizing factor. To test whether calcium antagonist treatment can restore NO availability and prevent hyperpolarization through antioxidant properties, in 15 healthy subjects and 15 patients with essential hypertension, we studied forearm blood flow (strain-gauge plethysmography) modifications induced by intrabrachial bradykinin (5, 15, 50 ng/100 mL per minute), an endothelium-dependent vasodilator, in basal conditions, during infusion of NG-monomethyl-l-arginine (L-NMMA, 100 microg/100 mL per minute), an NO-synthase inhibitor, and ouabain (0.72 microg/100 mL per minute), an Na+-K+ ATPase inhibitor to prevent hyperpolarization. These infusions were repeated in the presence of the antioxidant vitamin C (8 mg/100 mL/min). The response to sodium nitroprusside was also evaluated. In controls, vasodilation to bradykinin was inhibited by L-NMMA and remained unchanged by ouabain or vitamin C. In hypertensive patients, vasodilation to bradykinin was blunted and resistant to L-NMMA but sensitive to ouabain. Vitamin C increased the response to bradykinin and restored the inhibiting effect of L-NMMA while preventing the effect of ouabain. In hypertensive patients, infusions were repeated after 3-month treatment with lercanidipine (10 to 20 mg daily). Lercanidipine decreased plasma lipoperoxides, isoprostanes, and malondialdehyde and increased plasma antioxidant capacity. Moreover, lercanidipine increased the vasodilation to bradykinin and restored the inhibiting effect of L-NMMA on bradykinin-induced vasodilation while preventing the effect of ouabain. Finally, vitamin C no longer exerted its facilitating activity. These results indicate that in essential hypertension, lercanidipine increases endothelium-dependent vasodilation by restoring NO availability and preventing hyperpolarization, an effect probably determined by antioxidant activity.
机译:原发性高血压与由氧化应激诱导的一氧化氮(NO)分解和代偿性产生超极化因子引起的内皮依赖性血管舒张功能受损有关。为了测试钙拮抗剂治疗是否能通过15种健康受试者和15名原发性高血压患者通过抗氧化特性恢复NO的可用性并防止超极化,我们研究了臂内缓激肽引起的前臂血流(应变仪体积描记术)改变(5、15、50 ng / 100 mL /分钟),基础条件下,在灌注NG-单甲基-1-精氨酸(L-NMMA,100 microg / 100 mL每分钟),NO合酶抑制剂和哇巴因的基础条件下的内皮依赖性血管舒张剂(0.72 microg / 100 mL每分钟),一种Na + -K + ATPase抑制剂,可防止超极化。在抗氧化剂维生素C(8 mg / 100 mL / min)的存在下重复这些输注。还评估了对硝普钠的反应。在对照组中,L-NMMA抑制了缓激肽的血管舒张作用,而哇巴因或维生素C则保持不变。在高血压患者中,缓激肽的血管舒张作用减弱,对L-NMMA耐药,但对哇巴因敏感。维生素C增加了对缓激肽的反应,恢复了L-NMMA的抑制作用,同时阻止了哇巴因的作用。在高血压患者中,用lercanidipine治疗3个月后(每天10至20 mg)重复输注。乐卡地平降低血浆脂过氧化物,异前列腺素和丙二醛含量,并增加血浆抗氧化能力。此外,乐卡地平增加了对缓激肽的血管舒张,恢复了L-NMMA对缓激肽诱导的血管舒张的抑制作用,同时阻止了哇巴因的作用。最后,维生素C不再发挥其促进作用。这些结果表明,在原发性高血压中,乐卡地平可通过恢复NO的利用率和防止超极化来增加内皮依赖性的血管舒张作用,而这种作用可能是由抗氧化活性决定的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号